110,100 Shares in Express Scripts Holding Company (ESRX) Purchased by Harris Associates L P

Harris Associates L P purchased a new stake in Express Scripts Holding Company (NASDAQ:ESRX) in the second quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund purchased 110,100 shares of the company’s stock, valued at approximately $7,029,000.

A number of other institutional investors and hedge funds also recently made changes to their positions in the stock. Park National Corp OH lifted its position in Express Scripts Holding by 0.3% in the second quarter. Park National Corp OH now owns 3,575 shares of the company’s stock valued at $228,000 after acquiring an additional 11 shares during the last quarter. Parkside Financial Bank & Trust lifted its position in Express Scripts Holding by 0.3% in the second quarter. Parkside Financial Bank & Trust now owns 8,634 shares of the company’s stock valued at $551,000 after acquiring an additional 23 shares during the last quarter. Carroll Financial Associates Inc. lifted its position in Express Scripts Holding by 1.0% in the second quarter. Carroll Financial Associates Inc. now owns 3,186 shares of the company’s stock valued at $203,000 after acquiring an additional 30 shares during the last quarter. CAPROCK Group Inc. lifted its position in Express Scripts Holding by 0.9% in the second quarter. CAPROCK Group Inc. now owns 3,675 shares of the company’s stock valued at $235,000 after acquiring an additional 33 shares during the last quarter. Finally, Sandy Spring Bank lifted its position in Express Scripts Holding by 0.6% in the second quarter. Sandy Spring Bank now owns 6,464 shares of the company’s stock valued at $413,000 after acquiring an additional 37 shares during the last quarter. 88.69% of the stock is owned by hedge funds and other institutional investors.

WARNING: This report was first posted by TrueBlueTribune and is the property of of TrueBlueTribune. If you are reading this report on another website, it was stolen and reposted in violation of United States and international copyright & trademark law. The original version of this report can be viewed at https://www.truebluetribune.com/2017/10/13/110100-shares-in-express-scripts-holding-company-esrx-purchased-by-harris-associates-l-p.html.

Express Scripts Holding Company (ESRX) opened at 57.67 on Friday. The firm has a market capitalization of $33.31 billion, a price-to-earnings ratio of 10.01 and a beta of 0.88. The stock’s 50 day moving average is $61.96 and its 200-day moving average is $62.50. Express Scripts Holding Company has a 52 week low of $57.41 and a 52 week high of $77.50.

Express Scripts Holding (NASDAQ:ESRX) last issued its quarterly earnings data on Tuesday, July 25th. The company reported $1.73 earnings per share for the quarter, beating the Thomson Reuters’ consensus estimate of $1.71 by $0.02. The firm had revenue of $25.35 billion for the quarter, compared to the consensus estimate of $25.52 billion. Express Scripts Holding had a net margin of 3.50% and a return on equity of 25.58%. Express Scripts Holding’s quarterly revenue was up .5% compared to the same quarter last year. During the same period last year, the firm posted $1.57 EPS. On average, equities research analysts expect that Express Scripts Holding Company will post $6.99 EPS for the current year.

A number of equities research analysts recently weighed in on the stock. ValuEngine raised shares of Express Scripts Holding from a “hold” rating to a “buy” rating in a research report on Monday, October 2nd. BidaskClub raised shares of Express Scripts Holding from a “sell” rating to a “hold” rating in a research report on Saturday, June 17th. Robert W. Baird reissued a “hold” rating and issued a $56.00 price target on shares of Express Scripts Holding in a research report on Friday, September 1st. Needham & Company LLC assumed coverage on shares of Express Scripts Holding in a research report on Friday, July 21st. They issued a “hold” rating for the company. Finally, Raymond James Financial, Inc. reissued an “underperform” rating on shares of Express Scripts Holding in a research report on Monday. Six equities research analysts have rated the stock with a sell rating, eleven have given a hold rating, six have assigned a buy rating and one has given a strong buy rating to the stock. The stock currently has a consensus rating of “Hold” and a consensus target price of $69.45.

In related news, Director Woodrow A. Myers, Jr. sold 3,900 shares of Express Scripts Holding stock in a transaction dated Monday, September 11th. The shares were sold at an average price of $63.93, for a total value of $249,327.00. Following the sale, the director now directly owns 11,500 shares in the company, valued at approximately $735,195. The sale was disclosed in a legal filing with the SEC, which is available at the SEC website. Also, VP Phyllis S. Anderson sold 578 shares of Express Scripts Holding stock in a transaction dated Friday, September 8th. The shares were sold at an average price of $63.13, for a total transaction of $36,489.14. Following the completion of the sale, the vice president now owns 10,530 shares in the company, valued at $664,758.90. The disclosure for this sale can be found here. Over the last quarter, insiders sold 5,641 shares of company stock worth $357,317. 0.68% of the stock is currently owned by insiders.

Express Scripts Holding Company Profile

Express Scripts, Inc is a pharmacy benefit management (PBM) company in North America, offering a range of services to its clients, which include health insurers, third-party administrators, employers, union-sponsored benefit plans, workers’ compensation plans and government health programs. It operates in two segments: PBM and Emerging Markets (EM).

Institutional Ownership by Quarter for Express Scripts Holding (NASDAQ:ESRX)

Receive News & Ratings for Express Scripts Holding Company Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Express Scripts Holding Company and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Leave a Reply